Shandong Buchang Pharmaceuticals | Sustainability Performance
Researches, develops, and markets pharmaceutical products, offering traditional Chinese medicines and modern therapies across cardiovascular, oncology, and neurological treatment areas.
1993
China
5,001 - 10,000 employees
Pharmaceuticals
$1B - 10B in revenue
$25M - 100M in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#10772
Overallⓘ#762
in Chinaⓘ#260
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Financial Data
Business performanceCapital & innovationAnalyst projections
Controversy level
- Shandong Buchang Pharmaceuticals Co Ltd, Chinese TCM (Traditional Chinese Medicine) major, has faced sustained Chinese NMPA enforcement scrutiny over alleged inadequate disclosure of TCM injection product quality and the historic 2018 RMB 6+ billion bribery scandal involving sales representatives at multiple Chinese hospital customer sites affecting Chinese institutional shareholders.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
1
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.